The device is a continuation of NovaBone’s portfolio of bioactive bone grafts. It is designed as a rapidly-absorbable binder, and the open structure of the porous component allows for rapid vascularization and mineralization.
Read the news release about NovaBone.
Related Articles on Orthopedic Devices:
TranS1 Revenues Continue to Slide in 2Q With 26% Decrease
MedShape’s Ankle Fusion Device Receives FDA 510(k) Clearance
Integra LifeSciences Launces Anterior Cervical Fixation System
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
